HYUNDAI MOTOR GROUP OPENS NEW EUROPEAN TEST FACILITY TO LEAD DEVELOPMENT OF NEXTGENERATION TECHNOLOGY
Hyundai Motor Group reinforces commitment to Europe with ‘Square Campus’ expansion at…
Kia and Motability Operations Strengthen Collaboration to Deliver Inclusive Electric Mobility
Motability Operations and Kia sign MOU to enhance accessible mobility and advance…
Biban Forum 2025 Concludes in Riyadh with Agreements Worth Over USD 10.1 Billion and Record Global Participation
RIYADH, Saudi Arabia, Nov. 9, 2025 /PRNewswire/ -- The Small and Medium…
Quantinuum Selected by DARPA to Advance to Stage B of Quantum Benchmarking Initiative
With the industry's most advanced quantum systems and proven ability to scale,…
Workers at Aimbridge-operated hotels in Los Angeles and Philadelphia strike during event-filled weekend, UNITE HERE reports
Workers at hotels owned by RLJ Lodging Trust on both coasts walk…
In Response to a Broader FDA Investigation, ByHeart Initiates a Voluntary Recall of Two Batches of Infant Formula
NEW YORK--(BUSINESS WIRE)--ByHeart, a next-generation baby nutrition company, announced today that, out…
Cango Inc. Releases Letter to Shareholders
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today…
Cango Inc. Announces October 2025 Bitcoin Production and Mining Operations Update
HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango"…
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET Â | Source: Intellia Therapeutics, Inc. Deep, stable…
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.…